Rapid Micro Biosystems, Inc.
RPID
$3.03
$0.0953.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.29M | 29.65M | 28.05M | 26.17M | 24.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.29M | 29.65M | 28.05M | 26.17M | 24.71M |
| Cost of Revenue | 28.01M | 27.83M | 28.16M | 27.43M | 28.23M |
| Gross Profit | 2.28M | 1.82M | -109.00K | -1.26M | -3.52M |
| SG&A Expenses | 34.49M | 34.75M | 35.21M | 36.10M | 36.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.37M | 76.95M | 77.97M | 78.05M | 79.00M |
| Operating Income | -46.08M | -47.31M | -49.92M | -51.88M | -54.29M |
| Income Before Tax | -44.09M | -44.80M | -46.87M | -48.36M | -50.43M |
| Income Tax Expenses | 22.00K | 26.00K | 22.00K | 39.00K | 36.00K |
| Earnings from Continuing Operations | -44.11 | -44.83 | -46.89 | -48.40 | -50.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.11M | -44.83M | -46.89M | -48.40M | -50.46M |
| EBIT | -46.08M | -47.31M | -49.92M | -51.88M | -54.29M |
| EBITDA | -43.19M | -44.40M | -47.06M | -48.99M | -51.38M |
| EPS Basic | -1.00 | -1.02 | -1.08 | -1.11 | -1.17 |
| Normalized Basic EPS | -0.63 | -0.64 | -0.67 | -0.70 | -0.73 |
| EPS Diluted | -1.00 | -1.02 | -1.08 | -1.11 | -1.17 |
| Normalized Diluted EPS | -0.63 | -0.64 | -0.67 | -0.70 | -0.73 |
| Average Basic Shares Outstanding | 176.08M | 175.05M | 174.30M | 173.67M | 173.08M |
| Average Diluted Shares Outstanding | 176.08M | 175.05M | 174.30M | 173.67M | 173.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |